Publication | Open Access

Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis

VaccinationMog PeptideMucosal VaccinationVaccine DevelopmentAutoimmune DiseaseVaccine TargetImmunologyImmunodominanceSubcutaneous Inverse VaccinationAutoimmunityT Cell ImmunityVaccine DesignImmunotherapyMedicinePlga Particles